Wolfe Research analyst Mike Polark upgraded Sotera Health to Outperform from Peer Perform with a $25 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SHC:
- Sotera Health double-upgraded to Overweight from Underweight at Barclays
- Sotera Health ‘to rock’ with ‘massive overhang’ removed, says Wolfe Research
- Here’s What Caused Sotera Health’s (NASDAQ:SHC) Stunning Rally
- Sotera Health Announces Settlement of Ethylene Oxide Litigation in Illinois
- Sotera Health settles ethylene oxide litigation in Illinois for $408M